Umbilical venous catheterization (UVC) is a common practice in intensive neonatal care. However, a malpositioned UVC and its prolonged use may lead to various pro blems, including mechanical, infectious, and thrombotic complica tions in various organs such as the liver, lungs, and heart. Congenital chylous ascites is characterized by abnormally high levels of triglycerides in the peritoneal fluid of newborns, which originate from refluxed lymph within the abdominal cavity. Herein, we report a case of an UVC complication presenting as chyloperitoneum simulating congenital chylous ascites in a preterm neonate that resulted from total parenteral nutrition (TPN) extra vasation from a malpositioned UVC. Biochemical analysis of intraperitoneal chylous fluid and TPN infusate could help confirm the origin of chylo peritoneum. This case suggests that TPN extravasation from UVC should be considered when chyloperito neum develops in newborns with an indwelling catheter. UVC posi tions must also be carefully monitored at regular intervals to recognize associated complications early, particularly in cases with an inevitably malpositioned catheter related to the anatomy of the vessel course.
INTRODUCTION
Umbilical venous catheterization (UVC) has been widely used for central venous access to provide nutritional support in the intensive care of prematurely born infants intolerant to enteral supplementation. However, it may cause various complications due to inadequate positioning of UVCs 1, 2) . UVC malpositioning is related to the catheter tip, which is freely movable under physiological conditions such as lung expansion, diaphragmatic descent, and blood streaming force, or a failure in advancement of UVCs to an appropriate destination because of difficulty in negotiating certain anatomical sites 1) . UVC malpositioning, along with prolonged dwelling of a UVC, may lead to mechanical, infectious, and thrombotic complications of different organs such as the liver, lungs, and heart within or at 2 weeks after UVC insertion 1, 35) .
Ascites is an intraperitoneal collection of fluids (transudate, exudate, or chylous effusion) due to various causes, including vascular stream resistance due to portal hypertension, infection, inflammation, malignancy, and lymphatic system dysfunction 6, 7) .
Congenital fetal or neonatal chylous ascites is characterized
by the abnormally high levels of triglycerides in the peritoneal fluid, which originates from lymph (containing lymphoid cells, protein, and chylomicrons) that is prevented from circulating toward the venous system 8) . This is due to a wide range of con genital conditions that lead to lymphatic vessel impairment or obstruction within the abdominal cavity 7, 8) . The refluxed chyle derives from a dietary source with longchain triglycerides after birth 8) .
Herein, we report a case of a UVC complication that occurred in a preterm neonate and presented as an intraperitoneal chylo us fluid collection simulating congenital chylous ascites and resulted from total parenteral nutrition (TPN) extravasation due to improper UVC placement.
CASE REPORT
A Korean male infant with a birth weight of 2,960 g was born at 35 +2 weeks of gestation via repeat cesarean section delivery.
His immediate postnatal course was unremarkable except for mild respiratory distress syndrome, which responded well to conservative care. Gavage feeding was initiated but was not tolerated by the infant. Thus, an UVC was inserted for TPN on day 1 of life. The UVC insertion length was 10 cm, which was calculated with Shukla's formula 9) , using birth weight in kilo grams. Initial anteroposterior thoracoabdominal radiography revealed that the UVC tip was within the liver shadow below the right diaphragm (Figure 1 ), indicating that it might have been placed inside the right hepatic vein. Therefore, the catheter tip was withdrawn to 8 cm, which was lower than the acceptable position, to avoid possible hepatic complications. On day 2 of life, the UVC tip was pulled to 6 cm because the catheter tip was suspected to be located within the left hepatic vein. Gavage . Mutlu et al. 2) suggested that a catheter tip positioned between the T9 and T10 vertebrae is in the correct position. The acceptable and safe placement of an UVC is ascer 1) . The inves tigation of choice to confirm the placement of UVC tips has been proposed to be ultrasonography, which is superior to plain radiography 10, 11) . The insertion length of the UVC has been determined in accordance with birth weight (Shukla's formula) and shouldertoumbilicus distance 9, 12) . However, it may lead to incorrect UVC placement, particularly in prematurely born and lowbirthweight infants 1) .
To date, reported rates of UVC malpositioning range from 20% to 37% 2, 13) . Various complications, including hepatic, cardiac, and pulmonary lesions, have been found to be associated with UVC malpositioning depending on the location of the UVC tip. Hepatic problems (hematoma 1, 2, 14) , abscess 2) , laceration 15) , and transient portal venous gas 2) ) are frequently reported. They are related to low positioning of the UVC tip within the liver, infe rior to the IVC.
Cardiac (arrhythmia 4) , left atrial thrombus 1) , and pericardial effu sion causing cardiac tamponade 1) ) and pulmonary problems (edema, hemorrhage, infarction, and hydrothorax) 3) have risks for more severe outcomes. They are related to high positioning of the UVC tip inside the heart or lungs, superior to the IVC. Other complications associated with UVC insertion include intra peritoneal TPN extravasation presen ting as chylous ascites 1618) as in our case; central linerelated bloodstream infection, which occurs in up to 29% of central venous catheters placed 19) , largely due to retained catheters and by coagulasenegative staphylo cocci 4) ; and the presence of catheter remnant in the umbilicus after catheter removal 2) . In a 6year retrospective observational study of 974 newborns, Mutlu et al. 2) reported that the prevalence of UVCrelated complications was 20.3% (198 infants), of which malpositioning of the UVC tip (189 infants) is the most common as follows: low placement at 54% (102 patients), high placement at 32% (60 patients), and abnormal placement in the hepatic (26 patients) and splenic veins (one patient) at 14%.
Chylous intraperitoneal effusion in newborns is generally
suggestive of a diagnosis of congenital chylous ascites. However, as shown in our case, chyloperitoneum associated with UVC complications should be considered as a differential diagnosis.
Biochemical analysis can be used to discriminate whether the cumulative fluid originates from refluxed lymph or extravasated TPN infusate. In our case, the analysis confirmed that the yielded chylous ascites was derived from the TPN solution (Table 1 ). In addition, the following were used to rule out congenital chylous ascites: (1) in TPN, unlike enteral feeds, the bowel was bypassed, and parenteral nutritional support was given with a lipid source from a SMOFlipid 20% injection containing 30% mediumchain triglycerides, which did not require transport via the lymphatic system and contributed to chyle flow; (2) absence of ascites on fetal ultrasonography and lack of signs of ascites prior to the occurrence of abdominal distension after birth. Congenital chylous ascites is known to manifest as fetal and postnatal ascites of transudates 7, 8) .
The mechanism of chyloperitoneum by TPN extravasation from a malpositioned UVC can be postulated to occur in the This may explain the prompt occurrence of chyloperitoneum at 21 hours after final repositioning of the catheter tip, unlike other reports of hepatic complications presenting at 3 to 9 days after UVC insertion 1, 2, 14) . When abdominal distension developed, no intrahepatic lesion was found on ultrasonography, while plain radiography revealed the catheter tip likely located at the level of the umbilical vein.
In this patient, lower placement of the UVC was related to the anatomical shape of the path of the umbilical veinIVC, which made it difficult for the UVC tip to advance to the IVC. . Coley et al. 18) reported eight neonates with TPN ascites with low placement (intrahepatic location) of UVCs. They suggested that infused hypertonic TPN via UVC can produce local tissue necrosis and may disrupt the liver capsule, resulting in free intraperitoneal spillage of TPN 18) . No reports have described biochemical com parisons of the yielded ascitic fluid and TPN infusates 1618) . The biochemical analyses that was carried out in our study was useful in proving the origin of chylous effusion.
Management of chylous ascites depends on its etiology. Once UVC complications are suspected, prompt removal of the catheter is required 1) . Other measures may include conservative care or active treatments, including administration of anti coagulants and thrombolytics to prevent further lifethrea ten ing complications, which mainly occur in the case of higher positioned UVCs within heart chambers and lung vessels 1) . To reduce and prevent this potential risk of severe UVC complications, prolonged UVC use should be avoided. Repeated ultrasonography examinations in addition to plain radiography should be performed to confirm the UVC tip location 1, 10, 11) . Abiramalatha et al. 1) emphasized the significance of repeated and regular bedside echocardiographic screening (once every 2 or 3 days while the UVC is in place) to monitor the location of the UVC tip, which can travel over time, especially for early detection of catheterrelated cardiac compli cations.
Consequently, our case suggests that TPN extravasation from UVC should be considered when chyloperitoneum occurs in newborns with an indwelling catheter. Regular monitoring of UVC positions is crucial, and the UVC should be promptly re moved in case the catheter is found to be malpositioned.
